Axicabtagene ciloleucel (axi-cel)

Axicabtagene ciloleucel (axi-cel) is a groundbreaking cancer treatment known as CAR T-cell therapy. It involves modifying a patient's own immune cells to better recognize and attack cancer cells. Doctors extract a type of immune cell called T cells from the patient's blood and then engineer them in a lab to express a specific receptor that targets cancer. After this modification, the cells are infused back into the patient, where they can seek out and destroy cancerous cells, particularly useful in certain types of blood cancers like large B-cell lymphoma. It represents a significant advancement in personalized cancer care.